References
- Notelovitz M, Lenihan J P, McDermott M, Kerber I J, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000; 95: 726–731
- Jensen J, Christiansen C, Rødbro P. Cigarette smoking, serum estrogens and bone loss during hormone replacement therapy early after menopause. N Engl J Med 1985; 313: 973–975
- Bjarnason N H, Christiansen C. The influence of thinness and smoking on bone loss and response to HRT in early postmenopausal women. J Clin Endocrinol Metab 2000; 85: 590–596
- Bjarnason N H, Jørgensen C, Kremmer H, Alexandersen P, Christiansen C. Smoking reduces breast tenderness during oral estrogen-progestogen therapy. Climacteric 2004; 7: 390–396
- Andersen F S, Transbol I, Christiansen C. Is cigarette smoking a promotor of the menopause?. Acta Med Scand 1982; 212: 137–139
- Ward K D, Klesges R C. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001; 68: 259–270
- Cornuz J, Feskanich D, Willett W C, Colditz G A. Smoking, smoking cessation and risk of hip fracture in women. Am J Med 1999; 106: 311–314
- Terry P D, Rohan T E, Franceschi S, Weiderpass E. Cigarette smoking and the risk of endometrial cancer. Lancet Oncol 2002; 3: 470–480
- Byrjalsen I, Haarbo J, Christiansen C. Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy. Obstet Gynecol 1993; 81: 1016–1021
- Haarbo J, Hassager C, Jensen S B, Riis B J, Christiansen C. Serum lipids, lipoproteins and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates. Am J Med 1991; 90: 584–589
- Bjarnason N H, Byrjalsen I, Hassager C, Haarbo J, Christiansen C. Low dose estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am J Obstet Gynecol 2000; 183: 550–560
- Byrjalsen I, Thormann L, Meinecke B, Riis B J, Christiansen C. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy. Hum Reprod 1992; 7: 1042–1047
- Byrjalsen I, Bjarnason N H, Christiansen C. Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy. Am J Obstet Gynecol 1999; 180: 539–549
- Utian W H, Gass M L, Pickar J H. Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women. Menopause 2004; 11: 306–314
- Ma Q, Lu A Y. Origins of individual variability in P4501A induction. Chem Res Toxicol 2003; 16: 249–260
- Bjarnason N H. Drug metabolism and variability. N Engl J Med 2005; 353: 955–956